Organization
Ventyx Biosciences
3 clinical trials
Clinical trial
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Patients With Active Psoriatic ArthritisStatus: Terminated, Estimated PCD: 2024-01-02
Clinical trial
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Participants With Moderate to Severe PsoriasisStatus: Terminated, Estimated PCD: 2023-09-13
Clinical trial
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Participants With Moderately to Severely Active Crohn's DiseaseStatus: Active (not recruiting), Estimated PCD: 2024-06-01